Early growth response 2 and Egr3 are unique regulators in immune system

The immune system is evolved to defend the body against pathogens and is composed of thousands of complicated and intertwined pathways, which are highly controlled by processes such as transcription and repression of cellular genes. Sometimes the immune system malfunctions and a break down in self-tolerance occurs. This lead to the inability to distinguish between self and non-self and cause attacks on host tissues, a condition also known as autoimmunity, which can result in chronic debilitating diseases. Early growth response genes are family of transcription factors comprising of four members, Egr1, Egr2, Egr3 and Egr4. All of which contain three cyc2-His2 zinc fingers. Initially, Egr2 function was identified in the regulation of peripheral nerve myelination, hindbrain segmentation. Egr3, on the other hand, is highly expressed in muscle spindle development. Egr2 and Egr3 are induced due to the antigen stimulation and this signaling is implemented through the B and T cell receptors in the adaptive immunity. T cell receptor signaling plays a key role in Egr 2 and 3 expressions via their interaction with NFAT molecules. Egr 2 and 3 play a crucial role in regulation of the immune system and their involvement in B and T cell activation, anergy induction and preventing the autoimmune disease has been investigated. The deficiency of these transcription factors has been associated to deficient Cbl-b expression, a resistant to anergy phenotype, and expression of effector and activated T cells

Hospital facilities at home for heart failure patients

Background: Heart failure is a complex syndrome and also one of the common reasons for readmission following discharge. This condition imposes an enormous economic burden on healthcare sectors. The present research aimed to study the establishment of a home care system for patients with heart failure in order to evaluate the cost-effectiveness of this system and patient satisfaction. Methods: The present health system research selected 40 patients as the sample with eligible criteria. Care was provided by nurses based on physicians� instructions. In the first visit at home, a questionnaire on the quality of life was filled out by the patients or the nurses. The financial data of the medical records of the patients constituted the reference for the analysis of cost. After the intervention, the questionnaire on the quality of life was filled out by the patients once again and their satisfaction was measured. The data were statistically analyzed using the Python programming language and SPSS-16 at the 0.05 level of significance. Results: The length of stay in the hospital for each patient decreased from 2.1 days to 0.9 days per month. The number of annual hospitalizations also decreased from 5 to 3, and the number of annual outpatient visits showed a reduction from 46 to 38 for each patient. The results of the patient satisfaction assessment also indicated that most of the patients were satisfied with the services provided to them. Conclusions: The results showed that our study was cost-effective. We suggest that interventions be performed on larger scales so that the results can be used in the future as services available to patients with heart failure. © 2020, Iranian Heart Association. All rights reserved